Eye Diseases
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with primary acquired nasolacrimal duct obstruction with or without +ve regurge test
Exclusion criteria
Exclusion criteria: 1- Hypertensive patients. 2- Patients with known allergy to tranxemic acid. 3- Patients with bleeding disorder, or on anti-coagulant therapy. 4- Patients with coexisting nasal pathologies which could influence the outcome of the surgery. 5- Patients with history of trauma or laceration to the lacrimal passages. 6- During the menstrual cycle in females
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the amount of intraoperative bleeding (measured in millimeters) during external DCR using gauze soaked with combined tranexamic acid (100mg/ml) and epinephrine 1:200000 versus using gauze soaked only epinephrine 1:200000. | — |
Secondary
| Measure | Time frame |
|---|---|
| the mean surgical time of external DCR (measured in minutes) using gauze soaked with combined tranexamic acid (100mg/ml) and epinephrine 1:200000 versus using gauze soaked only epinephrine 1:200000. | — |
Countries
Egypt
Contacts
Assistant Lecturer of ophthalmology